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Inflammatoryboweldisease (IBD)hasbeenattributedto
aberrant mucosal immunity to the intestinal microbiota.
The transcription factor XBP1, a key component of the
endoplasmic reticulum (ER) stress response, is required
fordevelopmentandmaintenanceofsecretorycellsand
linked to JNKactivation.Wehypothesized that a stress-
ful environmental milieu in a rapidly proliferating tissue
might instigate a proinflammatory response. We report
that Xbp1 deletion in intestinal epithelial cells (IECs) re-
sults in spontaneous enteritis and increased suscepti-
bility to induced colitis secondary to both Paneth cell
dysfunction and an epithelium that is overly reactive to
inducers of IBD such as bacterial products (flagellin)
and TNFa. An association of XBP1 variants with both
formsof human IBD (Crohn’sdisease andulcerative co-
litis) was identified and replicated (rs35873774; p value
1.6 3 105) with novel, private hypomorphic variants
identified as susceptibility factors. Hence, intestinal in-
flammation can originate solely from XBP1 abnormali-
ties in IECs, thus linking cell-specific ER stress to the
induction of organ-specific inflammation.
INTRODUCTION
In eukaryotes, signals emanating from the endoplasmic reticu-
lum (ER) induce a transcriptional program that enables cells tosurvive ER stress. This highly coordinated response, the
unfolded protein response (UPR), facilitates the folding, process-
ing, export, and degradation of proteins emanating from the ER
during stressed conditions (Ron and Walter, 2007). Three distinct
UPR signaling pathways exist in mammalian cells that include ER
transmembrane inositol-requiring enzyme 1a and b (IRE1a and
b), pancreatic ER kinase (PERK), and activating transcription fac-
tor 6 (ATF6) (Wu and Kaufman, 2006). The most evolutionarily
conserved of these is the kinase/endoribonuclease IRE1, whose
activation by ER stress results in the excision of a 26 bp fragment
from the mRNA encoding the transcription factor X-box-binding
protein 1 (XBP1) by an unconventional splicing event that gener-
ates XBP1s, a potent inducer of a subset of UPR target genes
(Calfon et al., 2002). XBP1s is required for ER expansion (Shaffer
et al., 2004), the development of highly secretory cells such as
plasma cells and pancreatic and salivary gland epithelial cells,
and adaptation of tumor cells to hypoxic conditions and glucose
deprivation (Reimold et al., 2001; Lee et al., 2005). XBP1s directs
transcription of a core group of genes involved in constitutive
maintenance of ER function in all cell types, and a remarkably
diverse set of tissue- and condition-specific targets (Acosta-
Alvear et al., 2007; Lee et al., 2003b; Shaffer et al., 2004). Intes-
tinal epithelial cells (IECs) additionally express IRE1b, whose
deletion results in increased ER stress and exacerbated dextran
sodium sulfate (DSS) -induced colitis (Bertolotti et al., 2001).
We hypothesized that a stressful environmental milieu in
cells with high secretory activity might induce inflammation. If
so, inducing ER stress in vivo by cell-specificXbp1 deletion might
lead to organ-specific inflammation, providing a mechanistic
explanation for the initiation of proinflammatory diseases. WeCell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc. 743
Figure 1. Spontaneous Enteritis and Paneth Cell Loss in Xbp1–/– Mice
(A) Small intestinal mucosal scrapings (n = 8 per group) from Xbp1-deleted (XBP1–/–) and Xbp1-sufficient (XBP1+/+) mouse intestinal epithelium were analyzed for
cryptdin-1 (Defcr1), cryptdin-4 (Defcr4), cryptdin-5 (Defcr5), lysozyme (Lysz), mucin-2 (Muc2), cathelicidin (Camp1), and XBP1 (primers binding in the floxed
region) mRNA expression. Data are expressed as fold decrease in Xbp1–/– compared to Xbp1+/+ specimens, normalized to b-actin (mean ±SEM, Student’s t test).
(B) Fold increase in grp78 mRNA expression in Xbp1–/– compared to Xbp1+/+ epithelium, normalized to b-actin (n = 3 per group, mean ± SEM, Student’s t test).
(C) Spontaneous enteritis in Xbp1–/– mice (upper panels and lower left panel), and normal histology of Xbp1+/+ mice (lower right panel). Upper left, cryptitis with
villous shortening, crypt regeneration, and architectural distortion; upper right, neutrophilic crypt abscesses; lower left, duodenitis with surface ulceration and
granulation tissue.
(D) Paneth cells with typical eosinophilic granules on H&E-stained sections at the base of crypts in Xbp1+/+, but not Xbp1–/–, epithelium. Electron microscopy (EM)
with only rudimentary electron-dense granules (black arrows) and a contracted ER (white arrows) in Xbp1–/– basal crypt epithelial cells, normal configuration in
Xbp1+/+ mice. Immunohistochemistry (IHC) for the granule proteins lysozyme and procryptdin in Xbp1+/+ and Xbp1–/– epithelia.744 Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc.
focused on intestinal epithelium, which contains four highly
secretory epithelial cell lineages that are exposed to high con-
centrations of exogenous antigens: absorptive epithelium, gob-
let, Paneth, and enteroendocrine cells that are derived from
a common, constantly renewing intestinal epithelial stem cell
(Barker et al., 2007). We show that induction of ER stress in intes-
tinal epithelium through tissue- (and cell type-) specific disrup-
tion of Xbp1 results in spontaneous enteritis due to inability of
Xbp1-deficient IECs to properly generate antimicrobial activity
and respond appropriately to inflammatory signals in the local
milieu. Several single-nucleotide polymorphisms (SNPs) within
the XBP1 gene locus on chromosome 22q12.1 confer risk for
both types of inflammatory bowel disease (IBD), Crohn’s disease
(CD) and ulcerative colitis (UC), establishing the ER stress
pathway as a common genetic contributor to IBD in the human
population. We provide herein a comprehensive in vivo frame-
work for the manner in which hypomorphic variants of a novel
IBD-susceptibility gene (XBP1) links ER stress within the epithe-
lium to spontaneous intestinal inflammation.
RESULTS
Xbp1 Deletion in IEC Leads to ER Stress
and Spontaneous Enteritis
Xbp1flox/flox mice were generated by targeting loxP sites to introns
flanking exon 2, and bred onto Villin (V) -Cre transgenic mice (see
Figures S1A–S1C available online), that directs Cre recombinase
activity specifically to small and large intestinal epithelium (Mad-
ison et al., 2002).Xbp1flox/floxVCre (Xbp1–/–) offspring were born at
a Mendelian ratio and developed normally. Xbp1 exon 2 was effi-
ciently and functionally deleted specifically within the intestinal
epithelium (99% in small intestine, 87 ± 4% in colon) (Figures
1A, S1D, and S1E). Elevated basal grp78 levels in Xbp1–/– small
intestinal epithelia indicated increased ER stress (Figure 1B)
that was confirmed by microarray analysis showing both
increased grp78 (Haspa5) and Chop (Ddit3) (P = 0.02)
(Table S1; Figure S2A). Spontaneous small intestinal mucosal
inflammation, in association with increased ER stress, occurred
in 19/31 (61%) adult Xbp1–/– but not in (0/20) Xbp1+/+ mice
(c2P= 9.873106; Figure 1C). Notably, 5/16 (31%) heterozygous
Xbp1flox/wtVCre ‘‘Xbp1+/–’’ mice displayed mild spontaneous
small intestinal inflammation (c2 P = 0.007; Figure S2B). The in-
flammatory changes were patchy and ranged in severity from
lamina propria polymorphonuclear infiltrates to crypt abscesses
and frank ulcerations without granulomas (Figures 1C and S2B).
Absent Paneth Cells and Reduced Goblet Cells
in Xbp1–/– Epithelium
Xbp1–/– intestine was completely devoid of Paneth cells (Figures
1D and 1E), compared to Xbp1+/+ and Xbp1+/– mice (Figures 1E
and S2B). Paneth cell granules store lysozyme and proforms of
cryptdins, which were barely detectable in Xbp1–/– crypts(Figure 1D), and electron microscopy (EM) confirmed few
rudimentary electron-dense granules of minute size and a
compressed ER in Xbp1–/– Paneth cells (Figure 1D). mRNA
expression of cryptdins-1, -4, and -5 and lysozyme, but not cath-
elicidin, were substantially reduced (Figure 1A). We also noted
reduced numbers and size of goblet cells within the small intes-
tine but not colon with reduced secretory granules by EM and
reduced mRNA for the goblet cell protein MUC2 in Xbp1–/– small
intestinal epithelia (Figures 1A, 1E, 1F, and S2C). Enteroendo-
crine cells were unaffected (Figures 1G and S2D) and the epithe-
lial barrier function of absorptive epithelia was normal
(Figure 1H). Thus, Xbp1–/– mice exhibited a major defect in Pan-
eth cells and a minor defect in goblet cells in the small intestine
with an unperturbed epithelial barrier.
Xbp1 Deletion Results in Apoptosis of Differentiated
Paneth Cells and Exhibits Signs of a Regenerative
Response
Quantitative PCR (qPCR; b-catenin, Tcf4, Math1, Hes1;
Figure S3A), microarray analysis (Table S1), andb-catenin distribu-
tion (Figure S3B) of Xbp1–/– and Xbp1+/+ intestinal epithelium did
not reveal significant alterations in factors involved in intestinal ep-
ithelial cell fate decisions (Barker et al., 2007). We hypothesized
that the highly secretory Paneth cell might undergo programmed
cell death from failure to manage ER stress as observed in pancre-
atic acinar cells (Lee et al., 2005). Indeed, a few pyknotic, apoptotic
cells were detected in Xbp1–/– crypts (antiactive caspase-3+ and
TUNEL+; Figures 2A and S4A). To circumvent the problems asso-
ciated with detecting a low-frequency event (apoptosis) in a slowly
replenishing cell population, we generated Xbp1floxneo/floxneoVillin-
Cre-ER
T2
mice (Figure S1A). Along with efficient deletion of Xbp1
after initiation of tamoxifen treatment (Figure 2B), Paneth cell
numbers were reduced by 98% on day 7, paralleled by a similar
decrease in cryptdin-5 mRNA transcripts. Apoptotic epithelial
nuclei (Figures 2C and S4B) were observed after 2.7 days, peaked
at day 5, and declined on day 7 (Figure 2D). Apoptotic cells were
present at the base ofcrypts (Paneth cells), and invillousepithelium
(goblet cells) (Figure 2C). We observed a gradual increase of
TNFa and Chop (Ddit3) mRNA (Figures 2B and 2E), similar to
Xbp1–/– mice (Table S1; Figure S2A). We noted small intestinal
inflammation in individual Xbp1floxneo/floxneoVillinCre-ERT2 mice at
all time points analyzed (2.7, 5, and 7 days); focal enteritis was
present in 4 of 9 mice at day 5 (44%) ranging from lamina propria
polymorphonuclear infiltrates to crypt abscesses and frank ulcer-
ations (Figure 2F, upper two panels), despite only minor reduc-
tions in Paneth cells (Figure 2F, lower panel). Cumulatively, at
all time points examined, we observed enteritis in 7/18 (39%)
Xbp1floxneo/floxneoVillinCre-ERT2 and 0/7 controls after induction
with tamoxifen. The small intestinal epithelium exhibited villus
shortening with a reduction of the villus:crypt ratio (Figure 2G),
indicative of a regenerative response inXbp1–/– mice. A 1 hr pulse
of bromodeoxyuridine (BrdU) labeled the proliferative pool of(E) Enumeration of Paneth cells and goblet cells in small intestines (n = 5 per group, mean ± SEM, Student’s t test).
(F) Goblet cell staining by periodic acid Schiff (PAS) stain in Xbp1+/+ and Xbp1–/– epithelia. EM exhibited smaller cytoplasmic mucin droplets and a contracted ER
in Xbp1–/– goblet cells. No structural abnormalities were found in neighboring absorptive epithelia in Xbp1–/– mice.
(G) The marker for enteroendocrine cells, chromogranin, was detected by IHC in small intestines of Xbp1+/+ and Xbp1–/– mice.
(H) Xbp1+/+ and Xbp1–/– mice were orally administered FITC-dextran, and FITC-dextran serum levels were assayed 4 hr later (n = 7 per group, mean ± SEM).Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc. 745
Figure 2. Xbp1 Deletion Results in Apoptotic Paneth Cell Loss, Inflammation, a Distorted Villus:Crypt Ratio, and IEC Hyperproliferation
(A) Apoptotic nuclei were identified in Xbp1–/– (Xbp1flox/floxVCre) and Xbp1+/+ (Xbp1flox/flox) sections with antiactive (cleaved) caspase-3. Arrows point to apoptotic
cells.
(B) Xbp1floxneo/floxneoVCre-ERT2 mice were administered five daily intraperitoneal doses of 1 mg tamoxifen to induce deletion of the Xbp1floxneo gene in the intes-
tinal epithelium. XBP1, cryptdin-5 (Defcr5), and Chop mRNA (all expressed normalized to b-actin; left y axis) expression in epithelium during and after tamoxifen
treatment. Percentage of crypts with Paneth cells on H&E staining is shown (right y axis). Representative experiment of three performed.
(C) TUNEL and H&E staining on small intestinal sections of tamoxifen-treated Xbp1floxneo/floxneoVCre-ERT2 mice collected at the indicated days.
(D) TUNEL+ and caspase-3+ cells were enumerated by light microscopy (three mice per time point with ileal and jejunal sections each; mean ± SEM; p values
indicate comparisons to time point 0; Student’s t test).
(E) TNFa mRNA was quantified by qPCR in small intestinal epithelial scrapings from ileum harvested at the indicated time points after start of tamoxifen admin-
istration from VCre-ERT2 Xbp1floxneo/floxneo (n = 4 per time point) or Xbp1floxneo/floxneo (n = 1 per time point) mice. Mean ± SEM; p values indicate comparisons to
time point 0; Student’s t test.
(F) Enteritis in the small intestine in VCre-ERT2 Xbp1floxneo/floxneo mice on day 5 after tamoxifen administration. Upper left panel, 1003; upper right panel, same
section, 4003, arrow points to a crypt abscess; lower panel 1003, crypts with Paneth cells (arrows).746 Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc.
intestinal stem cells, and was similar in Xbp1+/+ and Xbp1–/– mice
(Figure 2H). However, 24 hr after BrdU injection, labeled cells
were detected higher up in the crypt-villus axis in Xbp1–/– mice,
indicating an increased migration rate (Figure 2H). Thus, XBP1
affects IEC homeostasis both through controlling cell renewal
and cell death.
Xbp1 Deletion Impairs Mucosal Defense to Oral Listeria
monocytogenes Infection
Xbp1–/– small intestinal lysates and supernatants lacked detect-
able lysozyme in response to carbamyl choline (CCh) (Figure 3A)
Figure 3. XBP1 Deficiency in Epithelium Results in Impaired
Antimicrobial Function
(A) Lower panel: small intestinal tissue from Xbp1+/+ and Xbp1–/– mice was
homogenized, resolved on SDS-PAGE, and detected by anti-lysozyme IgG
and GAPDH to ensure equal loading. Upper panel: small intestinal crypts iso-
lated from Xbp1+/+ and Xbp1–/– animals were stimulated with 10 mM carbamyl
choline (CCh). Supernatants were precipitated, resolved on SDS-PAGE, and
detected by anti-lysozyme IgG. Blots are representative of two independent
experiments.
(B) Small intestinal crypts were stimulated with LPS for 30 min, and superna-
tants were assayed for bactericidal activity. Data are expressed as % killing
compared to unstimulated crypts (triplicates, mean ± SEM), and are represen-
tative of two independent experiments.
(C) Intestinal epithelial cell-specific Xbp1–/– mice (n = 9) and Xbp1+/+ littermates
(n = 9; 5–10 weeks of age) were perorally infected with 3.6 3 108 L. mono-
cytogenes. Feces was aseptically collected 10 hr after infection and colony
forming units (c.f.u.) of L. monocytogenes were determined. Data are
presented as c.f.u. per mg dry weight of feces.
(D) Oral infection with L. monocytogenes was performed as in (C), liver and
spleen were aseptically harvested 72 hr after infection, and c.f.u. of L. mono-
cytogenes were determined (Xbp1+/+, n = 20; Xbp1–/–, n = 17). Data are
expressed as c.f.u. per organ. A two-tailed Mann-Whitney test was performed
for (C) and (D).or lipopolysaccharide (LPS) (not shown), and LPS-elicited
Xbp1–/– crypt supernatants lacked bactericidal killing activity
(Figure 3B). Oral infection with Listeria monocytogenes, a Gram-
positive intracellular pathogen that is affected by Paneth cell de-
fects (Kobayashi et al., 2005), revealed that 10 hr after infection,
100-fold higher numbers of colony forming units (c.f.u.) of L.
monocytogenes were recoverable from feces of Xbp1–/– com-
pared to Xbp1+/+ mice (Figure 3C). Translocation into liver and
spleen after 72 hr revealed a 10-fold higher number of L. monocy-
togenes recovered from Xbp1–/– livers, but similar numbers from
spleen (Figure 3D). These data suggest that XBP1 in Paneth cells
is required to decrease the luminal burden of L. monocytogenes.
XBP1 Deficiency Results in Enhanced Responses
of IECs to Typical Mucosal Inflammatory Signals
XBP1 mRNA splicing is a marker of IRE1 activation and ER stress
(Calfon et al., 2002; Lin et al., 2007). Virtually complete splicing of
mutant XBP1 mRNAs in Xbp1–/– small and large intestine and
partial splicing in Xbp1+/– small intestine was observed in con-
trast to barely detectable splicing in Xbp1+/+ mice (Figure 4A),
indicating IRE1 hyperactivation. JNK phosphorylation was in-
creased in Xbp1–/– small intestinal epithelia compared to con-
trols, consistent with the described TRAF2-dependent function
of IRE1 to activate JNK (Urano et al., 2000) (Figure 4B). To test
whether XBP1-mediated intestinal inflammation arose from in-
creased JNK activity in a microbiota- and cytokine-free system,
we silenced XBP1 expression in the mouse IEC line MODE-K
with an siRNA retrovirus (iXBP) and used flagellin and TNFa as
proinflammatory stimulants (Lodes et al., 2004). TNFa and flagel-
lin increased JNK phosphorylation and CXCL1 production from
MODE-K.iXBP (50%–90% reduction of XBP1) compared to
MODE-K.Ctrl cells (Figures 4C–4E) that was dose-dependently
and specifically (Figures S5A and S5B) blocked by the JNK inhib-
itor SP600125 (Figures 4F and 4G), but did not affect CD1d-
restricted MODE-K antigen presenting function (van de Wal
et al., 2003) (Figure 4H). We conclude that impaired XBP1
expression directly heightens proinflammatory JNK/SAPK sig-
naling in IECs in response to environmental stimuli and may
contribute to Paneth, goblet cell, and MODE-K.iXBP apoptosis
(Figures 2A, 2C, 2D, S6A, and S6B).
XBP1 Deficiency Leads to Increased Susceptibility
to Experimental Colitis
The Xbp1–/– colon, unlike the small intestine, did not exhibit
spontaneous colitis, but colonic IECs displayed evidence of
increased ER stress (Figure 4A). We therefore examined the
in vivo effects of DSS, a toxin for mucosal epithelial cells that dis-
rupts barrier function (Strober et al., 2002). Xbp1–/– mice given
4.5% DSS in drinking water exhibited more severe wasting and
rectal bleeding than Xbp1+/+ littermates (Figures 5A and 5B). His-
tologically, Xbp1–/– colons displayed increased areas of mucosal
erosions, edema, and cellular infiltration along with increased(G) Jejunal sections of Xbp1flox/flox (Xbp1+/+; n = 7) and Xbp1flox/floxVCre (Xbp1–/–; n = 8) mice were assessed for their villus:crypt ratio on H&E stainings (ratios
ofR4:1 are considered normal for jejunum; mean ± SEM, Student’s t test).
(H) Xbp1flox/flox (Xbp1+/+) and Xbp1flox/floxVCre (Xbp1–/–) mice were administered bromodeoxyuridine (BrdU) intraperitoneally, and small intestinal sections were
harvested after 1 and 24 hr (n = 3 per genotype per time point). The 1 hr time point labels the pool of proliferating IECs in the crypts (mostly transit amplifying IEC),
whereas the 24 hr time point assesses the migration along the crypt-villus axis indicating the turnover of the IEC compartment.Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc. 747
crypt loss compared to Xbp1+/+ littermates (Figures 5C and 5D).
Xbp1+/– mice exhibited an intermediate phenotype (Figures 5A–
5C). Antibiotic treatment abrogated the differences in severity of
DSS colitis between Xbp1+/+ and Xbp1–/– mice (Figures S7A and
S7B), highlighting the importance of the commensal flora in the
colitis observed (Figures 5A–5D). Levels of TNFa, a central medi-
ator of inflammation in DSS colitis (Kojouharoff et al., 1997), were
elevated in DSS-treated Xbp1–/– versus Xbp1+/+ colonic tissues
with intermediate TNFa expression in Xbp1+/– mice (Figure 5E).
Human Ileal and Colonic Mucosa
in CD and UC Exhibit Signs
of ER Stress
We analyzed UPR activation in the intestine of healthy individuals
and CD and UC patients in ileal and colonic biopsies. grp78 ex-
Figure 4. XBP1 Deficiency Results in
Increased Inflammatory Tone of the
Epithelium
(A) Small intestinal and colonic epithelial mRNA
scrapings from Xbp1+/+, Xbp1+/–, and Xbp1–/–
mice were analyzed for XBP1mRNA splicingstatus.
(B) Small intestinal formalin-fixed sections were
stained with rabbit anti-phospho-JNK antibody,
and revealed a patchy staining pattern in Xbp1–/–,
but not Xbp1+/+, sections. Control rabbit mAb was
negative (not shown). Representative of n = 5 per
group.
(C) MODE-K.iXBP and MODE-K.Control were stim-
ulated for the indicated time periods with flagellin
(1 mg/ml) and TNFa (50 ng/ml) and analyzed for
P-JNK and total JNK by western blot.
(D) MODE-K.iXBP (filled circles) and MODE-K.Ctrl
(open circles) cells were stimulated for 4 hr with
flagellin, and supernatants were assayed by ELISA
for CXCL1. Triplicates, mean ± SEM.
(E) Experiment as in (D), with TNFa.
(F) MODE-K.iXBP (circles) and MODE-K.Ctrl
(diamonds) cells were stimulated with either
10 mg/ml flagellin (filled symbols) or media alone
(open symbols) for 4 hr with the JNK inhibitor
SP600125, and supernatants were assayed for
CXCL1. Triplicates, mean ± SEM.
(G) As in (F), MODE-K cells were stimulated with
50 ng/ml TNFa (filled symbols) or media alone
(open symbols).
(H) MODE-K.iXBP (filled circles) and MODE-K.Ctrl
(open circles) cells were loaded with the glycolipid
antigen a-galactosylceramide (aGC), fixed, and
cocultured with the CD1d-restricted NKT cell
hybridoma DN32.D3, and antigen presentation
was measured as IL-2 release from DN32.D3.
Triplicates, mean ± SEM.
pression was increased in inflamed ileal
CD mucosa and XBP1s levels were
increased in both inflamed and nonin-
flamed ileal CD biopsies (Figure 5F).
Similarly, XBP1s levels in inflamed and
noninflamed colonic CD and UC mucosa
were increased compared to those
from healthy individuals, and there was a trend toward increa-
sed grp78 expression in inflamed UC and CD specimens
(Figure 5G). These data indicate the presence of ER stress and
increased IRE1 activity in the ileum and colon of CD and UC
patients.
SNPs within the XBP1 Gene Region Are Associated
with IBD
Three previously reported genome-wide linkage studies inde-
pendently suggested linkage of the 22q12 region with IBD
(Hampe et al., 1999; Barmada et al., 2004; Vermeire et al.,
2004), with signals as close as 0.3 Mb from the XBP1 gene.
We examined a German patient cohort of 1103 controls and
550 CD and 539 UC patients (panel 1), genotyping for 20 tagging
SNPs (average SNP distance, 5.25 kb; Figures S8A–S8E),748 Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc.
Figure 5. XBP1 Deficiency Increases Sus-
ceptibility to DSS Colitis
(A) DSS (4.5%) was administered in drinking water
for 5 days and then replaced by regular drinking
water in Xbp1+/+ (n = 9), Xbp1+/– (n = 9), and
Xbp1–/– (n = 12) littermates (age 6–12 weeks).
Wasting is presented as % of initial weight,
mean ± SEM. A one-tailed Student’s t test was
performed.
(B) Presence of rectal bleeding during DSS colitis
was assessed daily and scored as in Experimental
Procedures. Mean ± SEM; Xbp1+/+ (n = 9), Xbp1+/–
(n = 9), Xbp1–/– (n = 12). A two-tailed Mann-
Whitney test was performed.
(C) Individual signs of inflammation of colonic
tissue harvested on day 8 of DSS colitis were
scored blindly. A two-tailed Mann-Whitney test
was performed, mean ± SEM.
(D) Typical colonic histology on day 8 of DSS
colitis. Arrows indicate borders of ulcers.
(E) mRNA expression (normalized to b-actin) of
inflammatory mediators was quantified by qPCR
in colonic specimens on day 8 of DSS colitis.
n = 4 per group. Mean ± SEM was analyzed by
a two-tailed Mann-Whitney test.
(F) Human ileum in Crohn’s disease exhibits signs
of ER stress. Inflamed (CD-I; n = 3) and non-
inflamed (CD-NI; n = 3) ileal biopsies from CD
patients and healthy control (Ctrl; n = 4) subjects
were analyzed for grp78 mRNA expression
(levels in controls were arbitrarily set at 1, and
CD-I and CD-NI levels are expressed as ratio to
controls; left y axis). XBP1 mRNA splicing is
expressed as the ratio of XBP1s:XBP1u (right
y axis). Mean ± SEM.
(G) Human colon mucosa in Crohn’s disease (CD)
and ulcerative colitis (UC) exhibits signs of ER
stress. Colonic biopsies from inflamed (-I) and
noninflamed (-NI) CD and UC patients (n = 3
each) and healthy control subjects (Ctrl; n = 4)
were analyzed for grp78 mRNA expression and
XBP1 splicing as described in (F).selected from HapMap data of individuals of European ancestry
using de Bakker’s algorithm as implemented in Haploview (Bar-
rett et al., 2005). Three SNPs were significantly associated with
IBD: rs5997391, rs5762795, and rs35873774 (Table 1). The last
SNP, located in intron 4/5 of XBP1, remained significantly asso-
ciated after correcting for multiple testing using Bonferroni
correction (p value = 0.0011).
We replicated this index finding by genotyping two additional
independent patient panels (panel 2: 1854 patients, 2042 con-
trols; panel 3: 1446 patients, 2177 controls) and reproduced
the significant association with two of these three index SNPs
in each panel (rs5997391 and rs5762795 in panel 2; rs5762795
and rs35873774 in panel 3; Table 1; Table S2). Significant as-
sociations of nine and six additional SNPs in panels 2 and 3,
respectively, with CD, UC, and/or IBD were obtained. Several
association signals in each panel were robust to correction for
multiple testing and remained significant after 10,000 permuta-
tions. The combined analysis of panels 1, 2, and 3 in a total of5322 controls and 2762 CD and 1627 UC patients identified a to-
tal of six SNPs associated with IBD that were robust after correc-
tion for multiple testing and significant after 10,000 permuta-
tions; the minor alleles of these six SNPs conferred protection
from IBD (Table 1; Figure S8A). The strongest associated variant
was rs35873774 (p value = 1.6 3 105). The odds ratio (OR) for
carriership of the rarer C allele of rs35873774 in the combined
IBD panel was 0.74 (95% confidence interval [CI], 0.66–0.84;
Table 1).
Among the 20 SNPs tested, markers 2–5, 7, 9–14, and 18–20
(Table 1) are located in a 99 kb large block. Table S3 summarizes
the haplotype analysis results of the seven-marker haplotype
tagging SNPs of this block (2–4, 9–10, 12, 18). Three of the eight
haplotypes were significantly associated with IBD after 10,000
permutations. Haplotypes 5 and 7 were protective, whereas 4
was a risk haplotype. Multiple logistic regression analysis of the
entire IBD panel including gender as a covariate revealed a best-
model fit with SNPs rs5997391 and rs35873774 (intron 4/5 ofCell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc. 749
Table 1. Association Results of 20 SNPs that Were Genotyped across the XBP1 Gene Region
Panel 1 Panel 2 Panel 3
Panel 1 + 2 + 3
(5322 controls,
2762 CD, 1627 UC)
e
P
Value
IBD
P
Value
IBD
OR
(95%
CI) IBD
0.097 0.086 1.07
(0.98–1.16)
0.058 0.000072b,c 0.79
(0.69–0.89)
0.22 0.031 1.08
(0.99–1.18)
0.62 0.22 0.98
(0.90–1.07)
2 0.30 0.00042b,c 0.85
(0.78–0.92)
0.39 0.22 0.92
(0.80–1.06)
0.025 0.86 1.00
(0.91–1.09)
0.60 0.34 0.94
(0.81–1.09)
469b 0.22 0.00012b,c 0.84
(0.78–0.92)
0.13 0.92 0.96
(0.87–1.05)
573b 0.25 0.00023b,c 0.85
(0.78–0.92)
147b,c 0.000092b,c 0.000016b,c 0.74
(0.66–0.84)
0.24 0.76 0.94
(0.85–1.04)
493b 0.19 0.00097b,c 0.85
(0.78–0.92)
0.13 0.19 0.91
(0.79–1.06)
0.55 0.38 0.93
(0.78–1.10)
0 0.68 0.47 0.97
(0.84–1.12)
0 0.70 0.055 0.88
(0.80–0.96)
0 0.81 0.46 0.94
(0.86–1.03)
0.28 0.25 0.94
(0.86–1.02)
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# dbSNP ID Position
Distance
(kb) A1
MAF
U
MAF
CD
MAF
UC
p
Value
CD
p
Value
UC
p
Value
IBD
MAF
U
MAF
CD
MAF
UC
p
Value
CD
p
Value
UC
p
Value
IBD
MAF
U
MAF
CD
MAF
UC
p
Value
CD
p
Valu
UC
1 rs714191 27,469,965 - C 0.18 0.19 0.18 0.45 0.79 0.53 0.18 0.18 0.18 0.39 0.84 0.45 0.18 0.20 0.19 0.078 0.48
2 rs5997391a 27,470,093 0.13 T 0.07 0.06 0.05 0.15 0.012 0.014 0.06 0.05 0.05 0.057 0.036 0.014 0.07 0.06 0.06 0.15 0.12
3 rs5752792a 27,478,313 8.22 C 0.16 0.17 0.18 0.50 0.085 0.15 0.17 0.18 0.19 0.45 0.099 0.19 0.18 0.19 0.18 0.21 0.58
4 rs6005863a 27,481,002 2.69 G 0.41 0.41 0.39 0.84 0.25 0.41 0.41 0.40 0.37 0.43 0.032 0.12 0.42 0.44 0.39 0.07 0.11
5 rs5762788 27,499,324 18.32 A 0.33 0.30 0.31 0.10 0.44 0.12 0.32 0.29 0.28 0.0032 0.024 0.00081b,c 0.32 0.33 0.28 0.70 0.01
6 rs6005879 27,502,868 3.54 A 0.05 0.04 0.05 0.17 0.94 0.39 0.05 0.04 0.05 0.016 0.52 0.032 0.05 0.05 0.05 0.45 0.55
7 rs5752797 27,504,552 1.68 T 0.17 0.18 0.17 0.85 0.83 0.98 0.18 0.16 0.16 0.11 0.18 0.065 0.18 0.21 0.17 0.00089b,c 0.70
8 rs5997403 27,505,938 1.39 T 0.05 0.04 0.05 0.25 0.99 0.48 0.04 0.04 0.04 0.091 0.76 0.15 0.04 0.04 0.05 0.79 0.53
9 rs5762795a 27,507,054 1.12 A 0.33 0.30 0.30 0.10 0.084 0.039 0.32 0.29 0.28 0.0082 0.016 0.0016b,c 0.32 0.33 0.28 0.73 0.00
10 rs2267131a 27,515,025 7.97 C 0.12 0.14 0.13 0.39 0.84 0.51 0.14 0.12 0.12 0.12 0.096 0.051 0.13 0.16 0.11 0.00353b 0.20
11 rs2097461 27,516,433 1.41 C 0.33 0.30 0.30 0.14 0.16 0.077 0.32 0.29 0.27 0.012 0.0044 0.0013b,c 0.32 0.33 0.28 0.67 0.00
12 rs35873774a 27,516,485 0.05 C 0.08 0.05 0.06 0.0028 0.028 0.0011b,c 0.07 0.07 0.06 0.82 0.30 0.53 0.08 0.05 0.05 0.00342b 0.00
13 rs2269578 27,521,397 4.91 C 0.12 0.13 0.13 0.71 0.52 0.54 0.13 0.12 0.11 0.10 0.089 0.043 0.13 0.15 0.12 0.017 0.27
14 rs3788409 27,522,705 1.31 G 0.33 0.30 0.31 0.12 0.39 0.11 0.32 0.30 0.28 0.025 0.029 0.0065 0.33 0.33 0.28 0.79 0.00
15 rs6005893 27,524,344 1.64 T 0.05 0.04 0.04 0.23 0.17 0.11 0.05 0.03 0.04 0.043 0.18 0.028 0.04 0.05 0.05 0.27 0.18
16 rs35679096 27,524,947 0.60 A 0.03 0.03 0.03 0.45 0.32 0.28 0.04 0.03 0.03 0.43 0.18 0.24 0.03 0.04 0.03 0.39 0.97
17 rs133440 27,535,932 10.99 C 0.04 0.04 0.03 0.44 0.19 0.21 0.05 0.05 0.03 0.96 0.099 0.54 0.05 0.04 0.06 0.40 0.06
18 rs5762839a 27,556,001 20.07 T 0.17 0.16 0.17 0.72 0.82 0.90 0.17 0.15 0.14 0.0039 0.032 0.0011b,c 0.17 0.19 0.15 0.092 0.10
19 rs5762852 27,567,027 11.03 C 0.17 0.18 0.17 0.59 0.65 0.54 0.17 0.16 0.15 0.14 0.11 0.064 0.17 0.19 0.15 0.13 0.09
20 rs5762853 27,569,785 2.76 G 0.24 0.24 0.24 0.94 0.73 0.80 0.24 0.22 0.22 0.029 0.11 0.017 0.24 0.27 0.23 0.050 0.48
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).XBP1). Logistic regression analysis did not reveal any statisti-
cally significant interaction between any of the 20 genotyped
SNPs in XBP1.
Deep Sequencing Reveals Multiple Rare Variants
Including Two Hypomorphic Variants that Might
Confer Risk
Linkage disequilibrium (LD) around the XBP1 gene, flanked by
two recombination hotspots (Figure S8B), is generally weak
(Figure S8E). The complex haplotype structure of the locus
(Table S3) suggested that multiple rare, private SNPs might con-
tribute to its IBD association. We resequenced all exons, splice
sites, and promoter regions in 282 unaffected controls and 282
CD and 282 UC patients, and exons and splice sites only in
an additional 282 UC patients (Table S4; Figure S9). Apart from
verifying 15 already annotated variants, 51 new polymorphisms
were identified, among them 39 rare SNPs detected once in
either the CD, UC, and/or control cohort. The discovery fre-
quency for rare SNPs was 5, 16, and 18 for 282 controls and
CD and UC patients, respectively. Sequencing of the coding
region in another 282 UC patients yielded another three novel
SNPs. Five novel nonsynonymous SNPs (nsSNPs; XBP1snp8,
XBP1snp17, XBP1snp22, XBP1snp29, XBP1snp30) were dis-
covered in the sequencing cohort of 1128 patients but not
controls. Taqman genotyping revealed the actual frequencies
of these five novel nsSNPs in panels 1 and 2. Notably, heterozy-
gous individuals were only observed among the case groups for
four of the five rare nsSNPs, whereas the fifth nsSNP
(XBP1snp22) occurred at equal frequencies in all groups (Table
S4; Figure S9). The novel nsSNPs were too rare to warrant formal
statistical analysis.
The nsSNPsXBP1snp8 (M139I) andXBP1snp17 (A162P) pres-
ent in IBD patients but not controls (Table S4) lead to amino acid
changes in the XBP1 hinge region between the bZiP and trans-
activation domains. XBP1snp17 in exon 4 is 10 bp upstream of
the XBP1 mRNA splice site recognized by IRE1. We engineered
the respective mutations into unspliced (hXBP1u) and spliced
(hXBP1s) versions and transiently cotransfected MODE-K cells
with wild-type or mutant XBP1 plasmids and an UPRE-luciferase
reporter construct (Lee et al., 2003b). hXBP1u.M139I and
hXBP1s.M139I had diminished UPRE transactivating function
compared to wild-type plasmids in untreated and tunicamy-
cin- (Tm) treated MODE-K (Figures 6A and 6B). hXBP1u.A162P
displayed impaired UPRE transactivation only in Tm-treated
MODE-K cells (Figure 6A), whereas hXBP1s.A162P transactiva-
tion was unaltered (Figure 6B). To test the ability to induce XBP1s
target genes, we reconstituted Xbp1–/– mouse embryonic fibro-
blasts (MEFs) (Iwakoshi et al., 2003) with either wild-type or
mutant hXBP1u-GFP retroviral constructs, obtaining similar GFP
fluorescence and comparable protein levels (Figures 6C and
6D). hXBP1.M139I induced less ERdj4 (DNAJB9) and EDEM
(EDEM1) mRNA than hXBP1 wild-type both at baseline and
upon Tm treatment, whereas hXBP1u.A162P was hypomorphic
only under conditions of ER stress (Figure 6E) as above
(Figures 6A and 6B). hXBP1.P15L (XBP1snp22), the only rare
nsSNP present at similar frequencies in IBD patients and
controls, was not hypomorphic in these assays (Figures S10A
and S10B).Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc. 751
Figure 6. Rare XBP1 Variants Are Hypomorphic
(A) MODE-K cells were transfected with UPRE-luciferase and unspliced hXBP1u expression plasmids encoding the rare, IBD-associated minor alleles XBP1snp8
(M139I) and XBP1snp17 (A162P) and treated with 1 mg/ml tunicamycin (Tm). Values represent luciferase activities normalized to cotransfected Renilla reporter.
Duplicates, mean ± SD.
(B) Experiments as in (A), with indicated amounts of spliced hXBP1s cDNA variants.
(C) Transduction efficiency measured by fluorescence-activated cell sorting (FACS) of Xbp1–/– MEF cells reconstituted with human XBP1 wild-type or SNP
variants bicistronic retroviral vectors (RVGFP) (MFI, mean fluorescence intensity; GFP, green fluorescent protein; FSC, forward scatter).
(D) XBP1s protein levels were determined by western blot of Tm-treated cells (*, nonspecific band).
(E) ERdj4 and EDEM mRNA levels (normalized to b-actin mRNA expression) in untreated (NT) or Tm- (1 mg/ml; 6 hr) treated Xbp1–/– MEF cells transduced with
hXBP1u-GFP retroviral construct variants. Duplicates, mean ± SD.DISCUSSION
We present a spontaneous mouse model of intestinal inflamma-
tion that arises from a gene defect in an actual genetic risk factor
for human IBD. We suggest that XBP1 unifies key elements of
IBD pathogenesis within the IEC compartment, pointing toward
a primary defect in IEC function in IBD pathogenesis. Our results
introduce the ER stress response as a likely integral component
of organ-specific inflammation. XBP1 controls organ-specific in-
flammation through two major mechanisms that are probably
codependent. First, Paneth cell function was strikingly impaired
in Xbp1–/– mice, as evidenced by diminished antimicrobial pep-
tide secretion and a compromised response to pathogenic bac-
teria. Second, XBP1 deficiency itself induced ER stress that led752 Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc.to a heightened proinflammatory response of the epithelium to
known IBD inducers flagellin and TNFa (Figure S11).
XBP1 and Environmental Factors
Consistent with our results, increased grp78 expression has
recently been reported in IBD patients (Shkoda et al., 2007; Hea-
zlewood et al., 2008). Whereas Shkoda et al. suggested that ER
stress occurs secondary to an inflammatory insult to IECs, our
data instead point to specific impairment of the ER stress re-
sponse as a cause, rather than a consequence, of intestinal
inflammation. This might be obvious in the context of the genetic
association of XBP1 variants with IBD reported here, but we
speculate that environmental factors may also impair XBP1 func-
tion (and hence the ER stress response). Monozygotic twin
studies have highlighted the importance of as yet unknown envi-
ronmental and/or epigenetic factors in the development of IBD
(Halfvarson et al., 2003). One might speculate that microbial-
or food-derived XBP1 inhibitors could interfere with the path-
ways described herein, particularly in a genetically susceptible
host, thus contributing to the development of intestinal inflam-
mation. Along those lines, a recent report found that a 21-mem-
bered macrocyclic lactam termed ‘‘trierixin’’ isolated from Strep-
tomyces sp. potently inhibits endogenous XBP1 splicing in an
epithelial cell line (Tashiro et al., 2007).
Paneth Cell Deficiency, IEC Inflammatory Tone,
and Enteritis
Although Paneth and absorptive epithelial cells have been linked
to intestinal inflammation (Kobayashi et al., 2005; Zaph et al.,
2007; Nenci et al., 2007; Wehkamp et al., 2005), neither Paneth
cell depletion (Garabedian et al., 1997), inability to convert pro-
cryptdins to cryptdins (Wilson et al., 1999), nor Nod2 deletion
(Kobayashi et al., 2005) cause spontaneous or induced intestinal
inflammation. A recent study reported development of sponta-
neous UC that is dependent on a specific ‘‘colitogenic’’ microbial
milieu arising in a genetically altered host that is vertically and
horizontally transmissible to genetically intact mice (Garrett
et al., 2007). However, such colitogenic microbiota does not
apparently arise in Paneth cell- or cryptdin-deficient mice (Gara-
bedian et al., 1997; Wilson et al., 1999; Kobayashi et al., 2005).
We conclude that bacterial ‘‘dysbiosis’’ alone is insufficient to
cause intestinal inflammation if unaccompanied by a proinflam-
matory state including that primarily of the epithelium.
XBP1 deficiency in IECs resulted in IRE1a hyperactivation
through an unidentified mechanism and increased JNK phos-
phorylation in the epithelial compartment in vivo. An increased
susceptibility to DSS colitis was reported in Ire1b–/– mice (Berto-
lotti et al., 2001). Although IRE1b deficiency did not lead to spon-
taneous enteritis, colitis, or Paneth cell depletion, baseline levels
of grp78 were elevated consistent with an active UPR in the ab-
sence of IRE1b. IECs are currently emerging as key mediators of
inflammatory and immune mechanisms in mucosal tissues. IEC
deletion of Ikkb (Zaph et al., 2007) or Nemo (Nenci et al., 2007),
both upstream of NFkB, resulted in mucosal immune dysfunc-
tion and spontaneous colitis, respectively, the latter as a conse-
quence of IEC barrier dysfunction. We find that even minor
deficiencies in XBP1 expression within IECs lead to spontaneous
enteritis, while leaving the intestinal barrier largely intact.
Genetic Association of XBP1 Polymorphisms with IBD
IBD is a complex polygenic disease as evidenced by the recent
discovery and replication of several genetic risk factors that
include NOD2, the 5q31 haplotype (SLC22A4, SLC22A5), the
5p13.1 locus (PTGER4), DLG5, the IL23 receptor, ATG16L1,
IRGM, and IL12B on 5q33, NKX2-3, PTPN2, the 17q23.2 and
17q11.1 loci, and NELL1 (Mathew, 2008). Because the function-
ally relevant variants for most of these loci and their role in IBD
pathogenesis remain to be identified, a coherent model from
gene to intestinal inflammation has yet to be developed, although
some of these risk alleles point toward abnormalities of innate im-
mune responses (e.g., NOD2) and autophagy (e.g., ATG16L1,
IRGM), adaptive immune functions (e.g., IL23R), and the intesti-nal epithelial barrier (e.g.,DLG5) in human IBD. Our studies reveal
abnormalities of the ER stress response as another pathway for
the development of intestinal inflammation and IBD.
We suggest that the linkage results obtained on chromosome
22 from three independent microsatellite-based genome scans
(Hampe et al., 1999; Barmada et al., 2004; Vermeire et al.,
2004) could reflect the associations of rare and common variants
of the XBP1 gene region reported here. A currently emerging
concept is that rare sequence variants with strong phenotypic ef-
fects might contribute substantially to variation in complex traits,
and the aggregated risk contribution may result in common traits
(Cohen et al., 2004; Gorlov et al., 2008), a view strongly sup-
ported by analyzing frequencies of synonymous and nonsynon-
ymous SNPs in an extensive data set. The authors found that the
distribution of SNPs predicted to be ‘‘possibly’’ and ‘‘probably’’
damaging was shifted toward rare SNPs compared with the MAF
distribution of benign and synonymous SNPs that are not likely to
be functional (Gorlov et al., 2008). We found rare SNPs three
times more frequently in the CD and UC sequencing cohorts
than the control cohort and validated five rare nonsynonymous
coding variants, four of them present only in IBD patients.
Functional studies revealed that two of these IBD-restricted
nonsynonymous SNPs behaved as hypomorphs as evidenced
by decreased transactivation of the UPR and induction of
XBP1s target genes, either in all conditions tested (XBP1snp8)
or in response to exogenous induction of ER stress (XBP1snp17).
This pattern of decreased transactivation upon transfection of
mutant XBP1 cDNAs was observed in IEC lines with endogenous
(wild-type) XBP1, as well as Xbp1–/– MEFs reconstituted with mu-
tant or wild-type XBP1. Hence, these rare, IBD-associated vari-
ants are indeed hypomorphic, as would be predicted for risk-con-
ferring variants from the mechanisms established through our
mouse model. Whereas the functional impact of nonsynonymous
SNPs can be estimated by in vitro studies as presented herein, the
biological significance and contribution to disease risk of the other
associated as well as rare SNPs located outside the coding region
is hard to predict; nonetheless, there are excellent examples that
those variants could have important functional consequences
(Birney et al., 2007; Libioulle et al., 2007). The phenomenon that
multiple rare variants contribute to the overall risk at a particular
locus most likely represents a common situation in many complex
polygenic diseases (i.e., every patient has a ‘‘private’’ risk SNP).
This is also exemplified by NOD2, which not only harbors few
common alleles strongly associated with CD but also multiple
rare alleles that—taken together—account for a substantial pro-
portion of disease risk attributed to that locus. It cannot be ex-
cluded though, taking the results of the haplotype analysis into
account, that common variants contribute to disease risk at the
XBP1 locus in addition to the excess of private variants in patients.
We assume that most given disease-associated genes will have
a widespectrumof allelicvariants, bothcommon andrare/private.
EXPERIMENTAL PROCEDURES
Mice
The generation of Xbp1flox/floxVCre and VCre-ERT2 transgenic mice is detailed
in Supplemental Data. All mouse protocols were approved by the Harvard
Standing Committee on Animals.Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc. 753
Reagents
The sources of antibodies, proteins, and inhibitors are as follows: rabbit phos-
pho-JNK, total-JNK, active (cleaved) caspase-3 (Cell Signaling Technology),
anti-lysozyme (DakoCytomation), anti-procryptdin (Ayabe et al., 2002) gener-
ously provided by A. Ouellette (University of California, Irvine), flagellin (Invivo-
gen), and TNFa (Peprotech). The JNK-1, -2, and -3 inhibitor SP600125 (Sigma),
p38 inhibitor SB203580, and MEK inhibitors PD98059 and U0126 (Calbio-
chem) were dissolved in DMSO as recommended. Carbamyl choline and
lipopolysaccharide (from Escherichia coli 0111:B4) (Sigma) were used at final
concentrations of 10 mM and 1 mg/ml, respectively.
Immunohistochemistry, TUNEL, and Electron Microscopy
Tissues were handled by standard methods as detailed in Supplemental
Experimental Procedures. Apoptotic cells were detected on paraffin-
embedded small intestine using a TUNEL-POD kit (Roche Applied Sciences).
Small intestinal tissue from sex-matched Xbp1+/+ and Xbp1–/– littermates was
fixed as previously described (see Supplemental Experimental Procedures)
and observed with a JEOL 1200EX TEM at 60 kV operating voltage.
Oral L. monocytogenes Infection
Sex- and age-matched groups of Xbp1+/+ and Xbp1–/– littermates were in-
fected under BL2 conditions using gastric gavage at 3.6 3 108 L. monocyto-
genes strain 10403s per mouse. Colony forming unit assays (feces c.f.u./mg
dry weight; liver and spleen c.f.u./organ) were performed as in Kobayashi
et al. (2005) and Supplemental Experimental Procedures.
Dextran Sodium Sulfate Colitis
Sex- and age-matched littermates (8–12 weeks) received 4.5% DSS (ICN
Biomedicals) in drinking water for 5 days and then regular water thereafter,
or neomycin sulfate and metronidazole (1.5 g/L) (Sigma). Antibiotic-treated
mice received 7% DSS. Weight was recorded daily and rectal bleeding was
assessed (0, absent; 1, traces of blood at anus or the base of the tail; 2, clearly
visible rectal blood). Histological and mRNA expression studies on RNeasy
kit-isolated colon RNA (QIAGEN) used mice sacrificed on day 8 after DSS
treatment. Histological scoring of colons was as in Garrett et al. (2007).
Crypt Isolation, Stimulation, and Bactericidal Activity Assays
Small intestinal crypts were isolated, stimulated with 10 mM CCh or 1 mg/ml
LPS, and lysozyme levels and bactericidal activity against 1 3 103 c.f.u. Sal-
monella typhimurium cs015 were measured following published protocols
(Ayabe et al., 2000) and Supplemental Experimental Procedures.
Bromodeoxyuridine Incorporation
Xbp1+/+ and Xbp1–/– littermates were injected with 1 mg bromodeoxyuridine
(BrdU; Becton Dickinson) in 500 ml PBS. Small intestinal tissue was harvested
after 1 or 24 hr and paraffin-embedded tissue was sectioned and stained with
anti-BrdU antibody (Becton Dickinson).
Epithelial RNA Isolation and Quantification
Xbp1+/+ and Xbp1–/– intestines were opened longitudinally, rinsed with cold
PBS, everted on a plain surface, RNAlater added, and epithelium immediately
scraped off using RNase-free glass slides. Total RNA isolated using RNAeasy
columns (QIAGEN) was reverse transcribed and quantified by SYBR green
PCR (Bio-Rad). For microarray analysis, RNAs isolated from three specimens
per genotype were pooled, and microarrays were carried out at the Biopoly-
mers Core Facility (Harvard Medical School) with mouse genome 430 2.0 array
(Affymetrix). Data analysis was performed with Agilent GeneSpring GX and
Affymetrix GCOS software under default parameter setting. Quantitative
PCR was performed as in Lee et al. (2003b). See Table S5 for PCR primers.
XBP1 Splicing Assay
XBP1 splicing was measured by specific primers flanking the splicing site
yielding PCR product sizes of 164 and 138 bp for human XBP1u and XBP1s,
and 171 and 145 bp for mouse XBP1. Products were resolved on 2% agarose
gels, and band intensity was determined densitometrically (Optiquant soft-
ware, Perkin Elmer).754 Cell 134, 743–756, September 5, 2008 ª2008 Elsevier Inc.XBP1 Silencing in MODE-K Cells
The SV40 large T-antigen-immortalized small intestinal epithelial cell line
MODE-K (gift of D. Kaiserlian, Institute Pasteur) was transduced as described
(Iwakoshi et al., 2003) with an XBP1-specific RNAi vector and a control vector
identical to Lee et al. (2003a) except that SFGDU3hygro was used, and knock-
down was confirmed by qPCR. MODE-K.iXBP and MODE-K.Ctrl were seeded
for CXCL1 experiments as described (Song et al., 1999) at 13 105 cells/well in
96-well plates, adhered for 2–4 hr, supernatant removed, and stimulated with
flagellin and TNFa for 4 hr or preincubated for 30 min with JNK, p38, and MEK
inhibitors, supernatants removed, and cells stimulated in fresh media with
flagellin and TNFa. CD1d-restricted antigen presentation by MODE-K cells
(van de Wal et al., 2003) is in Supplemental Experimental Procedures. JNK
phosphorylation was assessed in MODE-K cells seeded at 1 3 106 per well
in 6-well plates, allowed to form confluent monolayers over 48–72 hr, stimu-
lated with flagellin and TNFa for the indicated time periods, washed in ice-
cold PBS, and lysed in 500 ml RIPA buffer (50 mM Tris [pH 7.4], 150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) supple-
mented with protease (Complete, Roche Applied Science) and Ser/Thr and
Tyr phosphatase (Upstate) inhibitors.
Western Blot
Protein content of lysates was determined by BCA assay, and equal amounts
of lysates containing Laemmli buffer were boiled at 95C for 5 min, resolved on
10% SDS-PAGE (for MODE-K cell lysates) or 12% SDS-PAGE (for TCA precip-
itates of purified crypts), transferred to Protran membranes (Whatman),
blocked with 5% milk in TBS-T, incubated with primary antibody in 3%–5%
BSA in TBS-T at 4C overnight, washed, and incubated with a 1:2000 dilution
of HRP-conjugated anti-rabbit secondary antibody in 3%–5% milk in TBS-T
for 45 min at room temperature. Bands were visualized using SuperSignal
chemiluminescent substrate (Pierce).
Human Biopsy Samples
Ileal and colonic biopsies were obtained from randomly selected patients with
clinically, endoscopically, and histologically confirmed diagnosis of CD and
UC, as well as healthy control patients without any signs of intestinal inflamma-
tion. The diagnosis of CD and UC was confirmed by established criteria of
clinical, radiological, and endoscopic analysis, and from histology reports.
Informed consent was obtained and procedures were performed according
to approval by the local ethics committee of the Innsbruck Medical University.
Biopsies were collected in RNAlater (Ambion), RNA was isolated using
RNAeasy columns (QIAGEN), reverse transcribed, and used for quantitative
PCR and XBP1 splicing assays.
Patient Recruitment
German patients and controls in panels 1 and 2 almost completely overlap with
the panels termed A and B in two recently published studies (Franke et al.,
2007; Hampe et al., 2007). Panel 3 is unpublished. All patients were recruited
at the Charite´ University Hospital (Berlin, Germany) and the Department
of General Internal Medicine of the Christian-Albrechts-University (Kiel,
Germany), with support from the German Crohn and Colitis Foundation and
BMBF competence network ‘‘IBD.’’ Clinical, radiological, and endoscopic
(i.e., type and distribution of lesions) studies unequivocally confirmed the
diagnosis of CD or UC, with confirmative or compatible histological findings
(Nikolaus and Schreiber, 2007). In the case of uncertainty, patients were ex-
cluded from the study. German healthy control individuals were obtained
from the PopGen Biobank (Krawczak et al., 2006). Informed written consent
was obtained from all study participants. All collection protocols were ap-
proved by the Charite´ University Hospital and the Department of General Inter-
nal Medicine of the Christian-Albrechts-University ethics committees.
Genotyping and Sequencing
Genomic DNA was prepared and amplified as in Supplemental Experimental
Procedures, genotyping was performed using the SNPlex Genotyping System
(Applied Biosystems) on an automated platform, genotypes were generated
by automatic calling using Genemapper 4.0 software (Applied Biosystems),
and all cluster plots were reviewed manually. Prior to statistical analyses, qual-
ity checks (PHWE > 0.01, MAFcontrols > 1%, callrateR 90%) were applied to the
SNPs under study. Single-marker association and haplotype analyses, permu-
tation tests, calculation of pairwise LD, and SNP selection were performed
using Haploview 4.0 (Barrett et al., 2005). Haplotype blocks were automatically
defined as in Gabriel et al. (2002). Only haplotypes with population frequen-
cies > 1.0% were included in the final association analysis.
Single-marker disease associations and possible marker-marker interac-
tions were assessed for statistical significance by means of logistic regression
analysis (forward selection), as implemented in the procedure LOGISTIC of
the SAS software package (SAS Institute). Prior to analyses, individuals with
missing data were removed and genotypes were coded numerically.
Genomic DNA sequencing was performed using BigDye chemistry (Applied
Biosystems) according to the supplier’s recommendations (for primer
sequences, see Table S6) and analyzed as described in Supplemental Exper-
imental Procedures. Authenticity of the five novel discovered rare nsSNPs and
rs5762809 was checked by TaqMan genotyping (Applied Biosystems) on an
automated platform. For primer and probe sequences, see Tables S6 and
S7; for genotype counts, see Tables S2 and S4.
UPRE Reporter Assays
Expression plasmids hXBP1u and hXBP1s were engineered to incorporate the
XBP1snp17 (A162P), XBP1snp8 (M139I), and XBP1snp22 (P15L) minor vari-
ants using the GeneTailor site-directed mutagenesis system (Invitrogen).
See Supplemental Data for primers used. Transient transfection of MODE-K
cells followed by luciferase assays was performed as in Lee et al. (2003b).
Reconstitution of Xbp1–/– MEF cells was with bicistronic retroviral vectors
expressing GFP and human XBP1 constructed by inserting PCR-amplified
cDNAs for human wild-type and XBP1snp17 and XBP1snp8 variants into
RVGFP vector between BglII and SalI sites, as described previously (Iwakoshi
et al., 2003) and transduced as described (Lee et al., 2003b).
SUPPLEMENTAL DATA
Supplemental Data include 11 figures, 7 tables, and Supplemental Experimen-
tal Procedures and can be found with this article online at http://www.cell.
com/cgi/content/full/134/5/743/DC1/.
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